Skip to content

RAPID AFib Decision Aid for Stroke Prevention in Atrial Fibrillation

Atrial Fibrillation

The goal of this pilot clinical trial is to evaluate the utility of a new electronic patient decision aid for stroke prevention therapy in patients with atrial fibrillation. The main questions it aims to answer are:

Is the patient decision aid acceptable to both patients and physicians? Does the patient decision aid lead to more effective shared decision-making than standard care among patients with atrial fibrillation who are considering stroke prevention therapy? Participants with a recent diagnosis of atrial fibrillation will be enrolled before an upcoming specialist physician visit. Researchers will compare a pre-visit intervention consisting of standard educational materials plus use of the patient decision aid to educational materials alone to see if using the decision aid results in improved shared decision making during the clinic visit.

null

Participation Requirements

  • Sex:

    ALL

  • Eligible Ages:

    18 and up

Participation Criteria

Inclusion Criteria:

* Non-valvular AF diagnosed within 12 months, with any level of stroke risk assessed by CHA2DS2-VASc score.
* Age 18 or older
* Either no OAC treatment or treated for less than 90 days.
* Initial specialist AF visit scheduled in 7-30 days.

Exclusion Criteria:

* Valvular AF, defined, per Canadian Cardiovascular Society Guidelines, as AF in the presence of mechanical heart valves, rheumatic mitral stenosis, or moderate to severe nonrheumatic mitral stenosis.
* Currently prescribed dual antiplatelet therapy (ASA plus either clopidogrel, ticagrelor, or prasugrel) for an indication other than AF.
* Has an independent, non-AF indication for oral anticoagulation.
* Has a non-modifiable impediment to effective use of web-based tools. Examples include lack of internet access, lack of English literacy (Grade 5 level).

Study Location

Calgary Zone, Alberta Health Services
Calgary Zone, Alberta Health Services
Calgary, Alberta
Canada

Contact Study Team

Primary Contact

Stephen Wilton, MD

[email protected]
403-210-7102
Backup Contact

Joel Adekanye, MD

[email protected]
Vita Diagnostics
Vita Diagnostics
Calgary, Alberta
Canada

Contact Study Team

Primary Contact

Lou Kolman, MD

[email protected]
587-393-8482
Study Sponsored By
University of Calgary
Participants Required
More Information
Study ID: NCT05900414